Central nervous system metastases in patients with high-risk breast carcinoma after multimodality treatment
β Scribed by Ana M. Gonzalez-Angulo; Massimo Cristofanilli; Eric A. Strom; Aman U. Buzdar; Shu-Wan Kau; Kristine R. Broglio; Terry L. Smith; Gabriel N. Hortobagyi
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 93 KB
- Volume
- 101
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND Trastuzumab, which is a large monoclonal antibody that is efficacious in the treatment of patients with HERβ2/__neu__βoverexpressing, metastatic breast carcinoma, does not penetrate the bloodβbrain barrier and, thus, may allow the brain to become a sanctuary site for micr
## Abstract ## BACKGROUND: The aim of this study was to assess the role of systemic treatment after wholeβbrain radiotherapy (WBRT) in immunohistochemically defined biological subsets of breast cancer patients with brain metastases. ## METHODS: The group of 420 consecutive breast cancer patients
One hundred eleven patients with small cell carcinoma of the lung (SCLC) were histologically subtyped according to the recent consensus report by the Pathology Committee of the International Association for the Study of Lung Cancer. Using pretreatment material the authors examined retrospectively th
## Abstract ## BACKGROUND Familial hemophagocytic lymphohistiocytosis HLH (FHL) is fatal, unless patients are rescued with hematopoietic stem cell transplantation (SCT). Although the molecular identification of FHL now is possible at least in part from perforin gene study, many cases escape detect